EFFICACY OF A SECOND-LINE CALCINEURIN INHIBITOR FOR NEPHROTIC SYNDROME RESISTANT TO STANDARD THERAPY
- Authors: Chebotareva N.1, Prikhodina L.2, Shilov E.3
-
Affiliations:
- Research Institute of Uronephrology, I.M. Sechenov First Moscow State Medical University
- Moscow Research Institute of Pediatrics and Pediatric Surgery, Ministry of Health and Social Development of the Russian Federation
- I.M. Sechenov First Moscow State Medical University
- Issue: Vol 24, No 6 (2013)
- Pages: 62-64
- Section: Articles
- URL: https://journals.eco-vector.com/0236-3054/article/view/115709
- ID: 115709
Cite item
Open Access
Access granted
Abstract
The paper describes a clinical case of the successful use of the second calcineurin inhibitor tacrolimus in an adolescent with nephrotic syndrome resistant to therapy with corticosteroids and cyclophosphan, as well as a concise review of literature on the use of this drug in different forms of chronic glomerulonephritis.
Full Text
About the authors
N. Chebotareva
Research Institute of Uronephrology, I.M. Sechenov First Moscow State Medical University
Email: natasha_tcheb@mail.ru
Candidate of Medical Sciences
L. Prikhodina
Moscow Research Institute of Pediatrics and Pediatric Surgery, Ministry of Health and Social Development of the Russian FederationProfessor
E. Shilov
I.M. Sechenov First Moscow State Medical UniversityProfessor; Department of Nephrology and Hemodialysis, Faculty for Postgraduate Training of Physicians
References
- Мухин Н.А., Козловская Л.В, Бобкова И.Н. и др. Индуцируемые протеинурией механизмы ремоделирования тубулоинтерстиция и возможности нефропротекции при гломерулонефрите // Вестник РАМН. - 2005; 1: 3-8.
- Приходина Л.С., Турпитко О.Ю., Длин В.В. и др. Такролимус в лечении стероидрезистентного синдрома у детей // Нефрол. и диализ. - 2010; 12 (4): 265-70.
- Arikan H., Koc M., Cakalagaoglu F. et al. Tacrolimus rescue therapy in resistant or relapsing cases of primary glomerulonephritis // J. Nephrol. - 2008; 21: 713-21.
- Bajpai A., Bagga A., Hari P. et al. Intravenous cyclophosphamide in steroid-resistant nephrotic syndrome // Pediatr. Nephrol. - 2003; 18: 351-6.
- Butani L., Ramsamooj R. Experience with tacrolimus in children with steroid-resistant nephritic syndrome // Pediatr. Nephrol. - 2009; 24: 1517-23.
- Cattran D., Rao P. Long-term outcome in children and adults with classic focal segmental glomerulosclerosis // Am. J. Kidney Dis. - 1998; 32: 72-9.
- Choudhry S., Bagga A., Hari P. et al. Efficacy and safety of tacrolimus versus cyclosporine in children with steroid-resistant nephrotic syndrome: a randomized controlled trial // Am. J. Kidney Dis. - 2009; 53 (5): 760-9.
- Denton M., Magee C., Sayegh M.H. Immunosupressive strategies in transplantation // Lancet. - 1999; 353: 1083-91.
- Duncan N., Dhaygude A., Owen J. et al. Treatment of focal and segmental glomerulosclerosis in adults with tacrolimus monotherapy // Nephrol. Dial. Transplant. - 2004; 19: 3062-7.
- Faul C., Donnelly M., Merscher-Gomes S. et al. The actin cytoskeleton of kidney podocytes is a direct target of the antiproteinuric effect of cyclosporine A // Nat. Med. - 2008; 4: 931-8.
- Gulati S., Prasad N., Sharma R. et al. Tacrolimus: a new therapy for steroid-resistant nephritic syndrome in children // Nephrol. Dial. Transplant. - 2008; 23: 910-3.
- Li X., Li H., Ye H. et al. Tacrolimus therapy in adults with steroid- and cyclophosphamid-resistant nephrotic syndrome // Am. J. Kidney Dis. - 2009; 54 (1): 51-8.
- Loeffler K., Gowrishankar M., Yiu V. Tacrolimus therapy in pediatric patients with treatment-resistant nephritic syndrome // Pediatr. Nephrol. - 2004; 19: 281-7.
- Mendizabal S., Zamora I., Berbel O. et al. Micophenolat mofetil in steroid/ cyclosporine-dependent nephrotic syndrome // Pediatr. Nephrol. - 2005; 20 (7): 914-9.
- Oh J., Kemper M. Second-line options for refractory steroid-sensitive and -resistant nephritic syndrome // Exp. Rev. Clin. Pharmacol. - 2010; 13 (4): 527-37.
- Ponticelli C., Rizzoni G., Edefonti A. et al. A randomized trial of cyclosporine in steroid-resistant idiopathic nephrotic syndrome // Kidney Int. - 1993; 43: 1377-84.
- Schweda F., Liebl R., Riegger A. et al. Tacrolimus treatment for steroid-and cyclosporine-resistant minimal change nephrotic syndrome // Nephrol. Dial. Transplant. - 1997; 12: 2433-5.
- Segarra A., Vila J., Pou L. et al. Combined therapy of tacrolimus and corticosteroids in cyclosporin-resistant or-dependent idiopathic focal glomerulosclerosis: a preliminary uncontrolled study with prospective follow-up // Nephrol. Dial. Transplant. - 2002; 17: 655-62.
- Tocci M., Matkovich D., Collier K. et al. The immunosuppressant FK506 selectively inhibits expression of early T cell activation genes // J. Immunol. - 1989; 143: 718-26.
Supplementary files
